Follow-up of Post-spinal Implantable Neurostimulator PRECISION®
CompletedNCT02208999
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Assessing the long-term efficacy, complications, revision rates and final explantation of the device
Study details
- Official title
- Two-years Follow-up of Post-spinal Implantable Neurostimulator PRECISION®
- Conditions
- Chronic Refractory Neuropathic Pain
- Ischemic Peripheral Pain
- Interventions
- Device: Neurostimulator Precision
- Sponsor
- Cemka-Eval
- Collaborators
- Boston Scientific Corporation
- Start date
- 2013-12
- Primary completion
- 2017-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult patient receiving spinal implantation of a neurostimulator PRECISION ® ( primary implantation or reimplantation) Exclusion Criteria: * Refusal of patient * Patient whose long-term monitoring will not be possible
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02208999